2023
DOI: 10.1002/smll.202370006
|View full text |Cite
|
Sign up to set email alerts
|

Hypoxia‐Responsive Photosensitizer Targeting Dual Organelles for Photodynamic Therapy of Tumors (Small 1/2023)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…), which generates reactive oxygen radicals (ROS) that can kill tumor cells. [17][18][19][20] ROS, including singlet oxygen ( 1 O 2 ), peroxide (O 2…”
Section: Introductionmentioning
confidence: 99%
“…), which generates reactive oxygen radicals (ROS) that can kill tumor cells. [17][18][19][20] ROS, including singlet oxygen ( 1 O 2 ), peroxide (O 2…”
Section: Introductionmentioning
confidence: 99%
“…Various fluorescent nanomaterials, including quantum dots, carbon nanoparticles, and metal nanoparticles, have been developed for bacteria detection and sensing. [8][9][10][11][12][13] Metal-organic frameworks (MOFs) consist of metal ions (clusters) as nodes and organic ligands as linkers. Their high structure regularity, surface area, and porosity make them attractive candidates for diverse biological applications such as drug delivery, biocatalysts, and sensing.…”
Section: Introductionmentioning
confidence: 99%
“…Evidence showed that the biosynthesis efficiency of PpIX was positively correlated with the oxygen (O 2 ) concentration, because the rate-limiting enzyme coproporphyrinogen-III oxidase (CPOX) in the biosynthesis process of PpIX is oxygen-dependent. Unfortunately, malignant cell proliferation and insufficient neovascularization result in tumor hypoxia, which severely restricts the conversion of ALA to PpIX. Thus, the ROS production efficiency of PpIX is greatly limited in a hypoxic tumor environment. O 2 in tumor cells is consumed by mitochondrial respiration through the oxidative phosphorylation (OXPHOS) metabolic pathway. Consequently, inhibiting OXPHOS by targeting mitochondrial complexes in the mitochondrial electron transport chain (ETC) could economize endogenous O 2 and relieve tumor hypoxia. However, the nonspecific distribution, rapid blood clearance, and poor solubility of the OXPHOS inhibitors resulted in poor improvement of tumor hypoxia.…”
Section: Introductionmentioning
confidence: 99%